Skeletal dysplasia and myelopathy in congenital disorder of glycosylation type IA.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Jornal de Pediatria

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JPEDS.2005.08.048PMID 16423609
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Congenital disorders of glycosylation (CDG): It's all in it!

  2003cited by this paper
• Neurological presentation in pediatric patients with congenital disorders of glycosylation type Ia.

  2003cited by this paper
• Assessment of skeletal status in patients with congenital disorder of glycosylation type IA.

  2002cited by this paper
• A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases

  2001cited by this paper
• Neurological presentation of a congenital disorder of glycosylation CDG-Ia: implications for diagnosis and genetic counseling.

  2000cited by this paper
• Carbohydrate-deficient glycoprotein syndrome type I: a new cause of dysostosis multiplex

  1998cited by this paper
• Carbohydrate‐deficient glycoprotein syndrome with previously unreported features

  1994cited by this paper
• Hypertrophic obstructive cardiomyopathy in a neonate with the carbohydrate-deficient glycoprotein syndrome

  1992cited by this paper
• Neurological Findings in the Carbohydrate‐deficient Glycoprotein Syndrome

  1991cited by this paper

• A Review of Brain and Pituitary Gland MRI Findings in Patients with Ataxia and Hypogonadism

  2023cites this paper
• International clinical guidelines for the management of phosphomannomutase 2‐congenital disorders of glycosylation: Diagnosis, treatment and follow up

  2019cites this paper
• A mouse model of a human congenital disorder of glycosylation caused by loss of PMM2

  2016cites this paper
• Phenotype–genotype correlations in patients with Marinesco–Sjögren syndrome

  2014cites this paper
• The Skeletal Manifestations of Deranged Glycosylation

  2013cites this paper
• Thyroid function in PMM2-CDG: diagnostic approach and proposed management.

  2012cites this paper
• Congenital disorders of glycosylation.

  2012cites this paper
• The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia).

  2009cites this paper
• The skeletal manifestations of the congenital disorders of glycosylation

  2008cites this paper
• Primary skeletal dysplasia as a major manifesting feature in an infant with congenital disorder of glycosylation type Ia

  2008cites this paper
• Diagnostic dilemma's: The congenital disorders of glycosylation are clinical chameleons

  2008cites this paper
• Further delineation of spondylometaphyseal dysplasia with cone‐rod dystrophy

  2008cites this paper
• Expanding spectrum of congenital disorder of glycosylation Ig (CDG‐Ig): Sibs with a unique skeletal dysplasia, hypogammaglobulinemia, cardiomyopathy, genital malformations, and early lethality

  2007cites this paper